TEST BANK FOR ABRAMS’ CLINICAL DRUG
THERAPY RATIONALES FOR NURSING
PRACTICE 12TH EDITION GERALYN
FRANDSEN - ISBN/ISSN 9781975136130
1
,Table of Content
SECTION 1 the Conceptual Framework of Pharmacology Chapter 1 the Foundation of Pharmacology: Quality and
Safety Chapter 2 Basic Concepts and Processes
Chapter 3 Medication Administration and the Nursing Process of Drug Therapy
SECTION 2 Drug Therapy throughout the Lifespan
Chapter 4 Pharmacology and the Care of Infants and Pediatric Patients Medication Administration in Pediatrics
Chapter 5 Pharmacology and the Care of Adults and Geriatric Patients Chapter 6 Pharmacology and the Care of Pregnant
or Lactating Woman Chapter 7 Pharmacology and Women’s Health
Chapter 8 Pharmacology and Men’s Health
SECTION 3 Drugs Affecting the Hematopoietic and Immune Systems
Chapter 9 Drug Therapy for Coagulation Disorders Chapter 10 Drug Therapy for Dyslipidemia
Chapter 11 Drug Therapy for Hematopoietic Disorders Chapter 12 Drug Therapy: Immunizations
Chapter 13 Drug Therapy to Decrease Immunity Chapter 14 Drug Therapy for the Treatment of Cancer
SECTION 4 Drugs Affecting Inflammation and Infection
Chapter 15 Inflammation, Infection, and the Use of Antimicrobial Agents Chapter 16 Drug Therapy to Decrease Pain,
Fever, and Inflammation Chapter 17 Drug Therapy with Corticosteroids
Chapter 18 Drug Therapy with Beta-Lactam Antibacterial Agents Chapter 19 Drug Therapy with Aminoglycosides and
Fluoroquinolones
Chapter 20 Drug Therapy With Tetracycline’s, Sulfonamides, and Urinary Antiseptics Chapter 21 Drug Therapy With
Macrolides and Miscellaneous Anti-infective Agents Chapter 22 Drug Therapy for Tuberculosis and
Mycobacterium axiom Complex Disease Chapter 23 Drug Therapy for Viral Infections
Chapter 24 Drug Therapy for Fungal Infections Chapter 25 Drug Therapy for Parasitic Infections
SECTION 5 Drugs Affecting the Cardiovascular System
Chapter 26 Drug Therapy for Hypertension Chapter 27 Drug Therapy for Dysrhythmias
Chapter 28 Drug Therapy for Coronary Heart Disease Chapter 29 Drug Therapy for Shock and Hypotension Chapter 30
Drug Therapy for Heart Failure
SECTION 6 Drugs Affecting the Respiratory System
Chapter 31 Drug Therapy for Nasal Congestion and Cough
Chapter 32 Drug Therapy to Decrease Histamine Effects and Allergic Response Chapter 33 Drug Therapy for Asthma and
Bronchoconstriction
2
,SECTION 7 Drugs Affecting the Renal and Digestive Systems
Chapter 34 Drug Therapy for Fluid Volume Excess
Chapter 35 Nutritional Support Products, Vitamins, and Mineral Supplements Chapter 36 Drug Therapy for Weight
Management
Chapter 37 Drug Therapy for Peptic Ulcer Disease and Hyperacidity Chapter 38 Drug Therapy for Nausea and Vomiting
Chapter 39 Drug Therapy for Constipation and Elimination Problems Chapter 40 Drug Therapy for Diarrhea
SECTION 8 Drugs Affecting the Endocrine System
Chapter 41 Drug Therapy for Diabetes Mellitus
Chapter 42 Drug Therapy for Hyperthyroidism and Hypothyroidism Chapter 43 Drug Therapy for Pituitary and
Hypothalamic Dysfunction Chapter 44 Drug Therapy to Regulate Calcium and Bone Metabolism Chapter
45 Drug Therapy for Addison’s Disease and Cushing’s Disease
Section 9 Drugs Affecting the Autonomic and Central Nervous System
Chapter 46 Physiology of the Autonomic and Central Nervous Systems and Indications for the Use of Drug Therapy
Chapter 47 Drug Therapy for Myasthenia Gravis, Alzheimer’s disease, and Urinary Retention
Chapter 48 Drug Therapy for Parkinson’s disease, Urinary Spasticity, and Disorders Requiring Anticholinergic Drug
Therapy
Chapter 49 Drug Therapy with Opioids
Chapter 50 Drug Therapy with Local Anesthetics
Chapter 51 Drug Therapy with General Anesthetics
Chapter 52 Drug Therapy for Migraines and Other Headaches Chapter 53 Drug Therapy for Seizure Disorders and
Spasticity Chapter 54 Drug Therapy for Anxiety and Insomnia
Chapter 55 Drug Therapy for Depression and Mood Stabilization Chapter 56 Drug Therapy for Psychotic Disorders
Chapter 57 Drug Therapy for Attention Deficit Hyperactivity Disorder and Narcolepsy Chapter 58 Drug Therapy for
Substance Abuse Disorders
Section 10 Drugs Affecting the Eye, Ear, and Skin Chapter 59 Drug Therapy for Disorders of the Eye Chapter 60 Drug
Therapy for Disorders of the Ear Chapter 61 Drug Therapy for Disorders of the Skin
3
, Chapter 1, the Foundation of Pharmacology: Quality and Safety
A woman diagnosed with obsessive–compulsive disorder has been prescribed oral paroxetine hydrochloride.
What is the expected effect for this prescription?
Curative effect on symptoms
Systemic effect on symptoms
Local effect on symptoms
Parenteral effect on symptoms
ANS: B
Rationale: Drugs that produce systemic effects are taken into the body, circulated through the bloodstream to their sites of
action in various body tissues, and eventually eliminated from the body. Curative agents are given to cure a
disease process. In this case, paroxetine hydrochloride will control the symptoms but not cure the disorder.
Drugs with local effects, such as sunscreen and local anesthetics, act mainly at the site of application.
Paroxetine hydrochloride is not administered parenterally. Parenteral agents are administered
subcutaneously, intramuscularly, or intravenously.
PTS: 1 REF: p. 3, Introduction OBJ: 1
NAT: Client Needs: Physiological Integrity: Pharmacological and Parenteral Therapies TOP: Chapter: 1: The
Foundation of Pharmacology: Quality and Safety
KEY: Integrated Process: Nursing Process
BLM: Cognitive Level: Understand NOT: Multiple Choice
A client has been prescribed an antibiotic. This medication is a naturally occurring
Substance that has been chefG
mRiceA
alD
leeEm
SoBdOifOi.e.Sd.TW
.hCaOt Mi s another name for this type of medication?
Synthetic drug
Semisynthetic drug
Biotechnology drug
Prototype drug
ANS: B
Rationale: Semisynthetic drugs (e.g., many antibiotics) are naturally occurring substances that have been chemically
modified. Synthetic drugs are more standardized in their chemical characteristics, more consistent in their
effects, and less likely to produce allergic reactions. Biotechnology drugs involve manipulating DNA and
RNA and recombining genes into hybrid molecules that can be inserted into living organisms. Prototype
drugs are the first drug of a particular group to be developed.
PTS: 1 REF: p. 3, Drug Sources OBJ: 1
NAT: Client Needs: Physiological Integrity: Pharmacological and Parenteral Therapies TOP: Chapter: 1: The
Foundation of Pharmacology: Quality and Safety
KEY: Integrated Process: Nursing Process
BLM: Cognitive Level: Understand NOT: Multiple Choice
Which classification applies to morphine?
Central nervous system depressant
Central nervous system stimulant
4
THERAPY RATIONALES FOR NURSING
PRACTICE 12TH EDITION GERALYN
FRANDSEN - ISBN/ISSN 9781975136130
1
,Table of Content
SECTION 1 the Conceptual Framework of Pharmacology Chapter 1 the Foundation of Pharmacology: Quality and
Safety Chapter 2 Basic Concepts and Processes
Chapter 3 Medication Administration and the Nursing Process of Drug Therapy
SECTION 2 Drug Therapy throughout the Lifespan
Chapter 4 Pharmacology and the Care of Infants and Pediatric Patients Medication Administration in Pediatrics
Chapter 5 Pharmacology and the Care of Adults and Geriatric Patients Chapter 6 Pharmacology and the Care of Pregnant
or Lactating Woman Chapter 7 Pharmacology and Women’s Health
Chapter 8 Pharmacology and Men’s Health
SECTION 3 Drugs Affecting the Hematopoietic and Immune Systems
Chapter 9 Drug Therapy for Coagulation Disorders Chapter 10 Drug Therapy for Dyslipidemia
Chapter 11 Drug Therapy for Hematopoietic Disorders Chapter 12 Drug Therapy: Immunizations
Chapter 13 Drug Therapy to Decrease Immunity Chapter 14 Drug Therapy for the Treatment of Cancer
SECTION 4 Drugs Affecting Inflammation and Infection
Chapter 15 Inflammation, Infection, and the Use of Antimicrobial Agents Chapter 16 Drug Therapy to Decrease Pain,
Fever, and Inflammation Chapter 17 Drug Therapy with Corticosteroids
Chapter 18 Drug Therapy with Beta-Lactam Antibacterial Agents Chapter 19 Drug Therapy with Aminoglycosides and
Fluoroquinolones
Chapter 20 Drug Therapy With Tetracycline’s, Sulfonamides, and Urinary Antiseptics Chapter 21 Drug Therapy With
Macrolides and Miscellaneous Anti-infective Agents Chapter 22 Drug Therapy for Tuberculosis and
Mycobacterium axiom Complex Disease Chapter 23 Drug Therapy for Viral Infections
Chapter 24 Drug Therapy for Fungal Infections Chapter 25 Drug Therapy for Parasitic Infections
SECTION 5 Drugs Affecting the Cardiovascular System
Chapter 26 Drug Therapy for Hypertension Chapter 27 Drug Therapy for Dysrhythmias
Chapter 28 Drug Therapy for Coronary Heart Disease Chapter 29 Drug Therapy for Shock and Hypotension Chapter 30
Drug Therapy for Heart Failure
SECTION 6 Drugs Affecting the Respiratory System
Chapter 31 Drug Therapy for Nasal Congestion and Cough
Chapter 32 Drug Therapy to Decrease Histamine Effects and Allergic Response Chapter 33 Drug Therapy for Asthma and
Bronchoconstriction
2
,SECTION 7 Drugs Affecting the Renal and Digestive Systems
Chapter 34 Drug Therapy for Fluid Volume Excess
Chapter 35 Nutritional Support Products, Vitamins, and Mineral Supplements Chapter 36 Drug Therapy for Weight
Management
Chapter 37 Drug Therapy for Peptic Ulcer Disease and Hyperacidity Chapter 38 Drug Therapy for Nausea and Vomiting
Chapter 39 Drug Therapy for Constipation and Elimination Problems Chapter 40 Drug Therapy for Diarrhea
SECTION 8 Drugs Affecting the Endocrine System
Chapter 41 Drug Therapy for Diabetes Mellitus
Chapter 42 Drug Therapy for Hyperthyroidism and Hypothyroidism Chapter 43 Drug Therapy for Pituitary and
Hypothalamic Dysfunction Chapter 44 Drug Therapy to Regulate Calcium and Bone Metabolism Chapter
45 Drug Therapy for Addison’s Disease and Cushing’s Disease
Section 9 Drugs Affecting the Autonomic and Central Nervous System
Chapter 46 Physiology of the Autonomic and Central Nervous Systems and Indications for the Use of Drug Therapy
Chapter 47 Drug Therapy for Myasthenia Gravis, Alzheimer’s disease, and Urinary Retention
Chapter 48 Drug Therapy for Parkinson’s disease, Urinary Spasticity, and Disorders Requiring Anticholinergic Drug
Therapy
Chapter 49 Drug Therapy with Opioids
Chapter 50 Drug Therapy with Local Anesthetics
Chapter 51 Drug Therapy with General Anesthetics
Chapter 52 Drug Therapy for Migraines and Other Headaches Chapter 53 Drug Therapy for Seizure Disorders and
Spasticity Chapter 54 Drug Therapy for Anxiety and Insomnia
Chapter 55 Drug Therapy for Depression and Mood Stabilization Chapter 56 Drug Therapy for Psychotic Disorders
Chapter 57 Drug Therapy for Attention Deficit Hyperactivity Disorder and Narcolepsy Chapter 58 Drug Therapy for
Substance Abuse Disorders
Section 10 Drugs Affecting the Eye, Ear, and Skin Chapter 59 Drug Therapy for Disorders of the Eye Chapter 60 Drug
Therapy for Disorders of the Ear Chapter 61 Drug Therapy for Disorders of the Skin
3
, Chapter 1, the Foundation of Pharmacology: Quality and Safety
A woman diagnosed with obsessive–compulsive disorder has been prescribed oral paroxetine hydrochloride.
What is the expected effect for this prescription?
Curative effect on symptoms
Systemic effect on symptoms
Local effect on symptoms
Parenteral effect on symptoms
ANS: B
Rationale: Drugs that produce systemic effects are taken into the body, circulated through the bloodstream to their sites of
action in various body tissues, and eventually eliminated from the body. Curative agents are given to cure a
disease process. In this case, paroxetine hydrochloride will control the symptoms but not cure the disorder.
Drugs with local effects, such as sunscreen and local anesthetics, act mainly at the site of application.
Paroxetine hydrochloride is not administered parenterally. Parenteral agents are administered
subcutaneously, intramuscularly, or intravenously.
PTS: 1 REF: p. 3, Introduction OBJ: 1
NAT: Client Needs: Physiological Integrity: Pharmacological and Parenteral Therapies TOP: Chapter: 1: The
Foundation of Pharmacology: Quality and Safety
KEY: Integrated Process: Nursing Process
BLM: Cognitive Level: Understand NOT: Multiple Choice
A client has been prescribed an antibiotic. This medication is a naturally occurring
Substance that has been chefG
mRiceA
alD
leeEm
SoBdOifOi.e.Sd.TW
.hCaOt Mi s another name for this type of medication?
Synthetic drug
Semisynthetic drug
Biotechnology drug
Prototype drug
ANS: B
Rationale: Semisynthetic drugs (e.g., many antibiotics) are naturally occurring substances that have been chemically
modified. Synthetic drugs are more standardized in their chemical characteristics, more consistent in their
effects, and less likely to produce allergic reactions. Biotechnology drugs involve manipulating DNA and
RNA and recombining genes into hybrid molecules that can be inserted into living organisms. Prototype
drugs are the first drug of a particular group to be developed.
PTS: 1 REF: p. 3, Drug Sources OBJ: 1
NAT: Client Needs: Physiological Integrity: Pharmacological and Parenteral Therapies TOP: Chapter: 1: The
Foundation of Pharmacology: Quality and Safety
KEY: Integrated Process: Nursing Process
BLM: Cognitive Level: Understand NOT: Multiple Choice
Which classification applies to morphine?
Central nervous system depressant
Central nervous system stimulant
4
